Oncopeptides AB (publ) (LON:0RN4)
London · Delayed Price · Currency is GBP · Price in SEK 5.17
-0.02 (-0.39%)
At close: Oct 15, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 111.37 million as of October 17, 2025. Its market cap has increased by 233.11% in one year.
Market Cap
111.37M
Enterprise Value
116.65M
Revenue
3.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.17
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 111.37M, a decrease of -25.29%. That is a compound annual growth rate of -3.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 111.37M | 359.71% |
| Dec 30, 2024 | 24.23M | -57.05% |
| Dec 29, 2023 | 56.41M | -38.17% |
| Dec 30, 2022 | 91.23M | 76.11% |
| Dec 30, 2021 | 51.80M | -94.99% |
| Dec 30, 2020 | 1.03B | 80.19% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 197.53B |
| HSBC Holdings | 171.44B |
| Shell | 155.89B |
| Unilever | 113.48B |
| Rolls-Royce Holdings | 94.62B |
| Rio Tinto Group | 86.77B |
| British American Tobacco p.l.c. | 83.46B |
| GSK plc | 65.86B |